Marksans Pharma Limited

3 recalls Categories: Prescription Drugs

CGMP Deviations: detection of N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level

Oct 2, 2020 Prescription Drugs Nationwide View Details →

CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level

Jun 5, 2020 Prescription Drugs Nationwide View Details →